Kao (4452) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Operating income for H1 surged 68.2% year-over-year to ¥57.9 billion, with net sales up 6.7% to ¥788.0 billion, driven by structural reforms and core brand strength.
Gross margin rose 3.4 points and ROIC increased to 8.8%, reflecting profitability restoration and high-value product promotion.
Upward revision of full-year operating income forecast to ¥140.0 billion, with net income expected at ¥104.0 billion and EPS at ¥223.90.
Market share and profit margin increased for key brands; global rollout of high-value products accelerated.
Strong first-half performance led to an upward revision of full-year forecasts despite ongoing global uncertainties.
Financial highlights
H1 net sales: ¥788.0 billion (+6.7% year-over-year); operating income: ¥57.9 billion (+68.2%); net income: ¥44.8 billion (+63.4%).
Gross margin improved to 38.5%; operating margin to 7.4%; basic EPS: ¥93.41 (+64.9%).
Interim dividend set at ¥76.00 per share; annual dividend forecast at ¥152.00 per share.
Total assets reached ¥1,847.8 billion; equity attributable to owners at ¥1,056.0 billion as of June 30, 2024.
Net cash from operating activities was ¥64.1 billion; cash and cash equivalents at period end were ¥303.9 billion.
Outlook and guidance
Full-year net sales forecast raised to ¥1,600.0 billion (+4.4% YoY), operating income to ¥140.0 billion, and net income to ¥104.0 billion.
Basic EPS forecast revised up to ¥223.90; ROIC expected at 8.8%.
Cash dividend forecast at ¥152.00 per share.
Management expects challenging conditions in the second half due to China’s slowdown, geopolitical risks, and rising raw material costs.
Structural reforms expected to contribute ¥27.0 billion to operating income in FY2024.
Latest events from Kao
- Profits and sales rose, with a share split and higher dividends planned for FY2026.4452
Q4 20256 Feb 2026 - Profit and margin growth surged on reforms and premiumization, offsetting China cosmetics weakness.4452
Q3 202416 Jan 2026 - Profit and ROIC surged on reforms; 2025 targets further growth and global expansion.4452
Q4 20248 Jan 2026 - Operating income jumped 41.9% on 6.6% sales growth, with robust gains in Japan.4452
Q1 20258 Jan 2026 - Profitability and margins rose, driven by high-value products and Cosmetics recovery.4452
Q3 202516 Dec 2025 - Upward forecast revision and major share buyback follow strong H1 results and improved profitability.4452
Q2 202523 Nov 2025